Novartis

Title	Published Date
Novartis delivers strong financial results and four major approvals	20 July 2011
Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers	18 July 2011
Phase III trial of Novartis drug Afinitor® met primary endpoint	08 July 2011
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)	04 July 2011
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis	22 June 2011
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia	17 June 2011
Novartis drug Glivec® shows significant overall survival benefit	07 June 2011
Novartis highlights extensive data on numerous compounds at ASCO	02 June 2011
Novartis gains FDA approval for Afinitor®	06 May 2011
Novartis makes strong start for the year	20 April 2011

Didn't we got you connected? If not, please note the following magic buttons:
Facebook
Twitter
LinkedIn
RSS